This dual weight-reducing effect can be particularly beneficial for patients with type 2 diabetes and obesity, addressing two interconnected metabolic abnormalities simultaneously
White adipose tissue (which does express GIPR on mature adipocytes) is being heavily treated
Needles and syringes for injection are ordered separately
Chronic kidney disease requires restricting sodium to under 2,000mg daily (about 1 teaspoon of salt), phosphorus to 800-1,000mg, and potassium to 2,000-3,000mg depending on your stage of kidney function
It falls under the drug classes of antidiabetics and GLP-1 agonists
The molecule also validated GLP-1 drugs at a commercial scale that helped define the market now contested by Lillys tirzepatide, a dual GIP/GLP-1 receptor agonist